Clinical trial inspectors from the US and the European Union are making strides in a joint inspections pilot programme they embarked on last year to identify how good clinical practice inspections can be conducted more effectively1,2.
Joint inspections conducted by the Food and Drug Administration and national competent authorities in the EU under the FDA/European Medicines Agency GCP initiative to assess how the regulators can share best practices and leverage inspectional resources have improved the inspectional programmes of both agencies, a spokeswoman from the FDA told RAJ Pharma...
Please login to read the full article.
